Skip to content
MedsAcross

Medicine

Phenergan 12.5 mg tablet

Promethazine · Oral · Direct_Rx
Available on requestPrescription onlyUS FDA

Phenergan 12.5 mg tablet is a prescription medicine containing Promethazine for oral use, marketed by Direct_Rx, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° - 25°C (68° - 77°F). Protect from light.

Key facts

Active ingredient (INN)
Promethazine
Brand
Phenergan
Strength
12.5 mg
Dosage form
Tablet
Route
Oral
Packs
10 tablets, 12 tablets, 30 tablets
Marketing authorisation holder
Direct_Rx
Manufacturer
Direct_Rx
Origin register
US FDA, United States
Storage
Store at 20° - 25°C (68° - 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2022
Identifiers
DailyMed set ID eec705f7-123a-7926-e053-2a95a90af46dNDC 72189-402Application ANDA040596

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 tablet in 1 bottle72189-402-10Direct_Rx1 December 2022
12 tablet in 1 bottle72189-402-12Direct_Rx1 December 2022
30 tablet in 1 bottle72189-402-30Direct_Rx1 December 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 March 1951Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Promethazine 12.5 mg tablet.

Compare 1

Other strengths and forms of Promethazine

Clinical summary

Promethazine is a phenothiazine. It is available as tablets, injection and suppositories for oral, intramuscular and intravenous use. MedsAcross supplies Promethazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Promethazine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Phenergan 12.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.